This funding opportunity supports research to develop in vitro and ex vivo assays and perform iterative screening to identify and characterize potential therapeutic agents targeting neurological or neuromuscular disorders. It aims to advance projects to meet entry criteria for translational programs such as the Blueprint Neurotherapeutics Network, facilitating early-stage translational research.
Eligible applicants include a wide range of U.S.-based organizations such as educational institutions, tribal organizations, nonprofits, government entities, and for-profit organizations including small businesses. Specific eligibility details should be confirmed in the full announcement.
